These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 3444369

  • 1. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
    Wilcox RW, Wykle RL, Schmitt JD, Daniel LW.
    Lipids; 1987 Nov; 22(11):800-7. PubMed ID: 3444369
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ.
    Cancer Res; 1992 May 15; 52(10):2835-40. PubMed ID: 1316230
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
    Hoffman DR, Hoffman LH, Snyder F.
    Cancer Res; 1986 Nov 15; 46(11):5803-9. PubMed ID: 3756924
    [Abstract] [Full Text] [Related]

  • 4. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC, Wykle RL, Modest EJ, Daniel LW.
    Cancer Res; 1989 Aug 15; 49(16):4441-5. PubMed ID: 2743333
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells.
    Chepenik KP, Wykle RL.
    Biochim Biophys Acta; 1992 Jun 22; 1126(2):192-8. PubMed ID: 1627622
    [Abstract] [Full Text] [Related]

  • 9. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F, Fernández-Luna JL, Gajate C, Martín-Martín B, Benito A, Martínez-Dalmau R, Modolell M.
    Cancer Res; 1997 Apr 01; 57(7):1320-8. PubMed ID: 9102220
    [Abstract] [Full Text] [Related]

  • 10. The metabolism of lyso-platelet-activating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla.
    Kawasaki T, Snyder F.
    Biochim Biophys Acta; 1987 Jul 13; 920(1):85-93. PubMed ID: 3036238
    [Abstract] [Full Text] [Related]

  • 11. Metabolism of platelet-activating factor in primary cultured adult rat hepatocytes by a new pathway involving phospholipase C and alkyl monooxygenase.
    Okayasu T, Hoshii K, Seyama K, Ishibashi T, Imai Y.
    Biochim Biophys Acta; 1986 Mar 21; 876(1):58-64. PubMed ID: 3947669
    [Abstract] [Full Text] [Related]

  • 12. Metabolism of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human promyelocytic leukemic HL60 cells. Stimulated expression of phospholipase A2 and acetyltransferase requires differentiation.
    Billah MM, Eckel S, Myers RF, Siegel MI.
    J Biol Chem; 1986 May 05; 261(13):5824-31. PubMed ID: 3084473
    [Abstract] [Full Text] [Related]

  • 13. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
    Herrmann DB, Ferber E, Munder PG.
    Biochim Biophys Acta; 1986 Mar 21; 876(1):28-35. PubMed ID: 3947667
    [Abstract] [Full Text] [Related]

  • 14. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
    Chao W, Siafaka-Kapadai A, Hanahan DJ, Olson MS.
    Biochem J; 1989 Jul 01; 261(1):77-81. PubMed ID: 2775221
    [Abstract] [Full Text] [Related]

  • 15. Identification of a lysophospholipase C that may be responsible for the biosynthesis of choline plasmalogens by Madin-Darby canine kidney cells.
    Strum JC, Daniel LW.
    J Biol Chem; 1993 Dec 05; 268(34):25500-8. PubMed ID: 8244986
    [Abstract] [Full Text] [Related]

  • 16. Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Small GW, Strum JC, Daniel LW.
    Lipids; 1997 Jul 05; 32(7):715-23. PubMed ID: 9252959
    [Abstract] [Full Text] [Related]

  • 17. Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
    Magistrelli A, Villa P, Benfenati E, Modest EJ, Salmona M, Tacconi MT.
    Drug Metab Dispos; 1995 Jan 05; 23(1):113-8. PubMed ID: 7720513
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of the effect of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine and some homologous compounds on PKC alpha and PKC epsilon.
    Conesa-Zamora P, Mollinedo F, Corbalán-García S, Gómez-Fernández JC.
    Biochim Biophys Acta; 2005 Feb 21; 1687(1-3):110-9. PubMed ID: 15708359
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
    Schick HD, Berdel WE, Fromm M, Fink U, Jehn U, Ulm K, Reichert A, Eibl H, Unger C, Rastetter J.
    Lipids; 1987 Nov 21; 22(11):904-10. PubMed ID: 3444383
    [Abstract] [Full Text] [Related]

  • 20. Differential metabolism of exogenous platelet-activating factor by glandular epithelial and stromal cells of rabbit endometrium.
    Kudolo GB, Yang YQ, Chen DB, Jones MA, Harper MJ.
    J Reprod Fertil; 1995 Nov 21; 105(2):315-24. PubMed ID: 8568777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.